Can hemolytic disease of the newborn be prevented in advance?
Oct 13, 2022
Source: Cainiu Health
Dr. Xie Zixing
Introduction
Hemolytic disease of the newborn refers to immune-mediated hemolysis caused by blood type incompatibility between mother and child. It can generally be prevented in advance. For example, both partners should undergo blood typing before pregnancy. If blood type incompatibility or other risk factors are identified, proactive preventive treatment should be undertaken. Rh-negative pregnant women can, as directed by a physician, receive an injection of anti-D immunoglobulin within 72 hours after delivery or miscarriage to reduce the risk of hemolytic disease in subsequent pregnancies.
Hemolytic disease of the newborn can generally be prevented in advance, helping to reduce its incidence.
In clinical practice, hemolytic disease of the newborn refers to immune-mediated hemolysis caused by blood type incompatibility between mother and baby. The most common types are ABO and Rh incompatibility. This condition may occur when maternal blood type antibodies cross the placenta into the fetal circulation, leading to increased destruction of fetal red blood cells. To prevent this, couples can undergo blood typing before pregnancy. If blood type incompatibility or other risk factors are identified, proactive prevention or treatment should be implemented to avoid hemolytic disease in the newborn. For example, Rh-negative pregnant women can receive an injection of anti-D immunoglobulin within 72 hours after delivery or miscarriage under medical guidance, which helps reduce the risk of hemolytic disease in future pregnancies.
Hemolytic disease of the newborn is potentially serious. Therefore, women should attend regular prenatal checkups after becoming pregnant, allowing early detection of any complications and timely intervention.
